StockData
Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN) KPIs and segments

ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$46.85−0.77 (-1.62%)

Close on Nov 17, 2026Market cap $3.43BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Enliven Therapeutics's business

Coming soon

This tab will track the numbers specific to Enliven Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?